Gulati Shraddha, Emmanuel Andrew, Inoue Haruhiro, Hayee Bu'Hussain, Haji Amyn
King's Institute of Therapeutic Endoscopy, London, UK.
Digestive Diseases Centre, Showa University Koto-Toyosu Hospital, Tokyo, Japan.
Clin Med (Lond). 2017 Feb;17(1):22-28. doi: 10.7861/clinmedicine.17-1-22.
Peroral endoscopic myotomy (POEM) is an established treatment for primary achalasia. It has gained endorsement from the American Society for Gastrointestinal Endoscopy with increasing clinical acceptance since the first procedure, performed in Japan in 2008. The first successful POEM in the UK was performed in November 2013 at King's College Hospital and this article presents the first UK case series. Prospective data were collected at 3 and 12-24 months for consecutive patients undergoing POEM. Post-POEM gastro-oesophageal reflux health-related quality of life scale (GORD-HRQoL) score was recorded. Statistical comparisons were made using paired non-parametric testing. In an initial series of 33 consecutive prospectively followed patients (12 female; 49.5±13 years; median follow-up 9 (3-28) months; 58% having had previous intervention), a 91% success rate has been achieved at 3 months. To date, 16 patients have reached the 12-month time point, with 13 (81%) sustaining response. This case series compares well with international cohorts and demonstrates excellent long-term safety and favourable efficacy.
经口内镜下肌切开术(POEM)是一种成熟的原发性贲门失弛缓症治疗方法。自2008年在日本开展首例手术以来,随着临床认可度的不断提高,它已获得美国胃肠内镜学会的认可。英国首例成功的POEM手术于2013年11月在国王学院医院进行,本文介绍了英国首个病例系列。对连续接受POEM手术的患者在术后3个月以及12至24个月收集前瞻性数据。记录术后经口内镜下肌切开术胃食管反流健康相关生活质量量表(GORD-HRQoL)评分。采用配对非参数检验进行统计学比较。在最初连续前瞻性随访的33例患者中(12例女性;年龄49.5±13岁;中位随访时间9(3-28)个月;58%曾接受过先前干预),3个月时成功率达到91%。迄今为止,16例患者已达到12个月时间点,其中13例(81%)维持有效。该病例系列与国际队列相比效果良好,显示出出色的长期安全性和良好的疗效。